Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

October 2020 Issue of The Medicine Maker

In this month’s issue of The Medicine Maker, we sit down with Richard M. Johnson, President, and Chief Executive Officer of the Parenteral Drug Association, who shares some career-defining experiences with us. In Business, we examine the state of US pharma and what the upcoming election could mean for the industry. Kiran Mazumdar-Shaw also shares the story behind Biocon’s biopharmaceutical success. In NextGen, we ask Duncan Peyton, Chief Executive Officer at 4D pharma about the importance of live biotherapeutics, and in our cover feature, we explore the challenges and opportunities that await African pharma.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Manufacture Quality & Compliance

Animal Alternatives

| Maryam Mahdi

How can we reduce animal testing in quality control procedures?
Manufacture Technology and Equipment

Top Tier Innovation

Nominate the top pharmaceutical technologies in our 2020 Innovation Awards.
Manufacture Formulation

The Drug Dose Gender Gap

| Maryam Mahdi

How can we achieve gender parity in drug dosing?
Manufacture Vaccines

Don’t Exclude the Aged

| Stephanie Sutton

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.
Business & Regulation Standards & Regulation

Importation Action

| Stephanie Sutton

How will new guidance issued by the FDA affect drug importation?
Business & Regulation Business Practice

Harnessing Dark Data

| Graeme Dennis

Graeme Dennis questions why the industry refuses to make use of the significant amount of data it generates.
Discovery & Development Drug Discovery

A Model Experiment

| Audrey Dubourg

Harnessing the potential of microphysiological systems to advance drug discovery.
Manufacture Quality & Compliance

Zero Defects

| Massimo Mainetti

Lives and livelihoods depend on accelerating large molecule drug production, so biopharma companies must minimize defects and contamination.

Focus on Quality – and the Rest Will Follow

| Sponsored by Thermo Fisher Scientific

Amgen developed the Multi-Attribute Method (MAM) to obtain high-fidelity understanding of the quality of its own biologics. Click to read article
Business & Regulation Business Practice

Stemming the Brain Drain

| Kelly Chibale

What can African nations do to retain the talent necessary for building pharmaceutical infrastructure?
Business & Regulation Business Practice

Why the African Medicines Agency’s Hour Has Arrived

| Sarah Adam, Cyntia Genolet

Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?
Business & Regulation Business Practice

Crisis Point

| Maryam Mahdi

How is African pharma coping with the COVID-19 pandemic?
Manufacture Advanced Medicine

A Living Elixir?

| James Strachan

Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.
Manufacture Advanced Medicine

Serving a Rising Power

| Sponsored by GenScript Probio

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?
Business & Regulation Trends & Forecasts

The Battle for the Future of American Healthcare

| James Strachan

Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.
Business & Regulation Business Practice

Pacesetting Leadership

| Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw shares the experiences that have helped shape her career, and the lessons learned along the way.
Business & Regulation Profession

A Wealth of Experience

Sitting Down With… Richard M. Johnson, President, and Chief Executive Officer, Parenteral Drug Association.

Other issues of 2020